miércoles, 19 de enero de 2022

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

No hay comentarios:

Publicar un comentario